glp-1 agonists for type 2 diabetes Drug Savings: A Complete Guide How to Save on Ozempic, Wegovy, and More New GLP-1 Guidelines for Type

Description

doi: 10.1016/j.bbadis.2018.05.012 127 BruenRCurleySKajaniSCreanDOReillyMELucittMBet al

Abstract Glucagon-like peptide-1 receptor (GLP-1R) agonists have garnered significant attention for their therapeutic potential in addressing the interconnected health challenges of diabetes, obesity, and cancer

GLP-1s may help with OA by: Reducing overall inflammation Protecting cartilage in your joints Helping people lose weight takes pressure off the knees and hips Making walking and movement easier over time Studies found that GLP-1 and SGLT2 medicines may lower the risk of needing a knee replacement (for OA), though results varied

Your doctor will help you build a treatment plan that fits your goals, all from the comfort of your home

This study, which included around 6,400 patients, employed Cox regression analysis and confirmed that diabetic patients using GLP-1R agonistssuch as exenatide, liraglutide, dulaglutide, and semaglutide were less likely to receive a new glaucoma diagnosis (76)